Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta

J Pharmacol Exp Ther. 2006 Oct;319(1):155-64. doi: 10.1124/jpet.106.106286. Epub 2006 Jul 12.

Abstract

Iptakalim, a novel cardiovascular ATP-sensitive K(+) (K(ATP)) channel opener, exerts neuroprotective effects on dopaminergic (DA) neurons against metabolic stress-induced neurotoxicity, but the mechanisms are largely unknown. Here, we examined the effects of iptakalim on functional K(ATP) channels in the plasma membrane (pm) and mitochondrial membrane using patch-clamp and fluorescence-imaging techniques. In identified DA neurons acutely dissociated from rat substantia nigra pars compacta (SNc), both the mitochondrial metabolic inhibitor rotenone and the sulfonylurea receptor subtype (SUR) 1-selective K(ATP) channel opener (KCO) diazoxide induced neuronal hyperpolarization and abolished action potential firing, but the SUR2B-selective KCO cromakalim exerted little effect, suggesting that functional K(ATP) channels in rat SNc DA neurons are mainly composed of SUR1. Immunocytochemical staining showed a SUR1-rather than a SUR2B-positive reaction in most dissociated DA neurons. At concentrations between 3 and 300 microM, iptakalim failed to hyperpolarize DA neurons; however, 300 microM iptakalim increased neuronal firing. In addition, iptakalim restored DA neuronal firing during rotenone-induced hyperpolarization and suppressed rotenone-induced outward current, suggesting that high concentrations of iptakalim close neuronal K(ATP) channels. Furthermore, in human embryonic kidney 293 cells, iptakalim (300-500 microM) closed diazoxide-induced Kir6.2/SUR1 K(ATP) channels, which were heterologously expressed. In rhodamine-123-preloaded DA neurons, iptakalim neither depolarized mitochondrial membrane nor prevented rotenone-induced mitochondrial depolarization. These data indicate that iptakalim is not a K(ATP) channel opener in rat SNc DA neurons; instead, iptakalim is a pm-K(ATP) channel closer at high concentrations. These effects of iptakalim stimulate further pharmacological investigation and the development of possible therapeutic applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / drug effects
  • Adenosine Triphosphate / pharmacology*
  • Animals
  • Humans
  • Membrane Potentials / drug effects
  • Multidrug Resistance-Associated Proteins / drug effects
  • Potassium Channels / drug effects*
  • Potassium Channels, Inwardly Rectifying / drug effects
  • Propylamines / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Drug
  • Rotenone / pharmacology
  • Substantia Nigra / drug effects*
  • Sulfonylurea Receptors
  • Tolbutamide / pharmacology

Substances

  • ABCC8 protein, human
  • ATP-Binding Cassette Transporters
  • Abcc8 protein, rat
  • Kir6.2 channel
  • Multidrug Resistance-Associated Proteins
  • N-(1-methylethyl)-1,1,2-trimethylpropylamine
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Propylamines
  • Receptors, Drug
  • Sulfonylurea Receptors
  • mitochondrial K(ATP) channel
  • Rotenone
  • Adenosine Triphosphate
  • Tolbutamide